Otitis Media News and Research

RSS
Acute otitis media (AOM) is a common childhood disease with important ramifications to the overall health of infants and young children. The peak incidence of AOM occurs at 6 to 18 months of age, but it can also occur in older children. Complications of AOM include persistent middle ear effusion, chronic otitis media, transient hearing loss, or speech delays.
Genocea Biosciences acquires global license for novel Streptococcus pneumoniae antigens from Children’s Hospital Boston

Genocea Biosciences acquires global license for novel Streptococcus pneumoniae antigens from Children’s Hospital Boston

Prevenar 13: Immunogenic and well tolerated in young children previously vaccinated with Prevenar

Prevenar 13: Immunogenic and well tolerated in young children previously vaccinated with Prevenar

MiddleBrook Pharmaceuticals full-year 2009 revenues rise 67.7%

MiddleBrook Pharmaceuticals full-year 2009 revenues rise 67.7%

New study suggests rising childhood obesity is linked to food allergies

New study suggests rising childhood obesity is linked to food allergies

FDA approves Pfizer's Prevnar 13 pneumococcal conjugate vaccine

FDA approves Pfizer's Prevnar 13 pneumococcal conjugate vaccine

FDA approves Wyeth Pharmaceuticals' Prevnar 13 pneumococcal disease vaccine

FDA approves Wyeth Pharmaceuticals' Prevnar 13 pneumococcal disease vaccine

Taking zinc supplements reduces otitis media in healthy children: No clear evidence

Taking zinc supplements reduces otitis media in healthy children: No clear evidence

FDA clears Otonomy's IND for clinical trial of OTO-104 in Meniere's disease patients

FDA clears Otonomy's IND for clinical trial of OTO-104 in Meniere's disease patients

Scientists identify bacterial protein VpsT as master regulator in Vibrio

Scientists identify bacterial protein VpsT as master regulator in Vibrio

FDA and PATH collaborate to advance pneumococcal vaccine development for children

FDA and PATH collaborate to advance pneumococcal vaccine development for children

Clinical results of MedImmune's pivotal trial for motavizumab published

Clinical results of MedImmune's pivotal trial for motavizumab published

Pfizer provides update on Prevnar 13

Pfizer provides update on Prevnar 13

Health Canada approves Prevnar 13 vaccine for invasive pneumococcal disease

Health Canada approves Prevnar 13 vaccine for invasive pneumococcal disease

Immuno Laboratories and TRPN sign agreement to reduce chronic illness

Immuno Laboratories and TRPN sign agreement to reduce chronic illness

Pfizer's Prevenar 13 granted European marketing authorization

Pfizer's Prevenar 13 granted European marketing authorization

FDA Advisory Committee votes in support of Pfizer's Prevnar 13

FDA Advisory Committee votes in support of Pfizer's Prevnar 13

Treatment of allergic rhinitis can improve nasal and ocular symptoms

Treatment of allergic rhinitis can improve nasal and ocular symptoms

Middlebrook Pharmaceuticals announces financial and operational results for third quarter 2009

Middlebrook Pharmaceuticals announces financial and operational results for third quarter 2009

Complications of otitis media: Evolving trends in children

Complications of otitis media: Evolving trends in children

Study links improving air quality and fewer cases of cases of ear infections in children

Study links improving air quality and fewer cases of cases of ear infections in children